Phoenix is pleased to announce its latest investment in Medmark, Ireland’s largest and most established occupational healthcare provider. The investment, which is subject to standard regulatory approvals, will support the company’s next phase of growth and innovation.
Founded in 1987, Medmark supports more than half a million employees through a range of occupational health, health screening, workplace medical assessment and employee wellbeing services. Operating from nine locations across the island of Ireland, the company is the market leader in Ireland in occupational health, serving public and private sector organisations of all sizes and helping employers to create safer and healthier workplaces.
This deal builds on Phoenix’s decades of experience in the healthcare space, joining investments such as Envisage and London Gynaecology.
Phoenix’s partnership with Medmark will help the organisation accelerate strategic initiatives already underway. This includes expanding its clinical and operational teams, investing further in technology and digital health platforms, enhancing customer reporting and service delivery, and broadening its geographic reach. The investment will also support Medmark in pursuing complementary acquisition opportunities and developing new services to meet the evolving occupational health and workplace wellbeing needs of employers across Ireland.
Dr Robert Ryan and Paul O’Grady will continue to lead Medmark’s day-to-day operations and strategic direction, with Phoenix supporting the business through board-level involvement, capital investment and access to operational expertise to help accelerate growth and development initiatives.
On the investment, Barry Robinson, Partner at Phoenix, comments:
“From our first meeting with Robert and Paul, we have been hugely impressed by the market leading business they have built. At the core of their success has been a clear and consistent focus on clinical excellence over many years, supported by an outstanding and people centric culture.
“Each of our investments is underpinned by deep sector research and a strong belief in the founders’ vision, and we believe Medmark is well placed to benefit from growing demand for occupational health and workplace wellbeing services across Ireland.
“We are really excited to be partnering with Robert, Paul and the wider management team to support Medmark on the next stage of its growth journey.”
Matthew Mellon, Investment Director at Phoenix, adds:
“Our investment reflects our commitment to championing founder-led businesses in the healthcare sector. Medmark is the market leader in the Irish occupational health and wellness market, and its success is testament to the strength of Robert and Paul’s leadership and the wider Medmark team. We look forward to working closely with Robert and Paul to realise the next phase of Medmark’s growth.”
Dr Robert Ryan, CEO, Medmark, comments:
“This investment represents a landmark moment for Medmark and reflects the exceptional progress our team has made in recent years. What is particularly exciting about this next chapter is not only the opportunity to continue growing our business, but also to deepen the impact we have on the lives of those we serve.
“As demand continues to grow for occupational health, health screening and health surveillance services, we see significant opportunities to expand our contribution and continue delivering meaningful value for employees, employers, healthcare professionals and society more broadly, while ensuring the quality, clinical excellence, customer service and values that define Medmark remain unchanged.”
